Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

September 28, 2019

5 Ways to Have a Better MRI Experience With MS

  • MRI
    /
  • Multiple Sclerosis
    /
Probably no one enjoys having an MRI, but the experience can be made more bearable. Medically Reviewed by Samuel Mackenzie, MD,…
MRI

September 27, 2019

Boster’s Corner: Multiple Sclerosis Vlog: SUPPLEMENTS FOR MS? Vitamin D3 and much more

  • Boster's MS Corner
    /
  • MS Diet & Nutrition
    /
  • Vitamins and Supplements
    /
Aaron Boster MD September 2019 Supplements for Multiple Sclerosis? In this video I teach you about nutrition & dietary supplements…
Boster's MS Corner

September 27, 2019

a Boster Video: New MS Drug Results: #Ofatumumab vs #Teriflunomide (ASCLEPIOS trial)

  • Boster's MS Corner
    /
  • MS Drug Therapies
    /
Aaron Boster MD In this video I share brand new MS drug results, comparing a new B-cell killer (Ofatumamab) to…
Boster's MS Corner

September 27, 2019

7 Home Modification to Empower People with Multiple Sclerosis

  • Additional MS resource sites
    /
This Article is Provided by:  #MSViewsandNews :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
Additional MS resource sites

September 27, 2019

Neuropsychological tests useful tool for real life activity in MS

  • MS Research Study and Reports
    /
Sept 23, 2019 A recent review of research literature explored the relationship between neuropsychological assessment and predictability of performance of…
MS Research Study and Reports

September 27, 2019

Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

  • MS Drug Therapies
    /
In ASCLEPIOS I and II, ofatumumab (OMB157) met primary endpoints to reduce the annualized relapse rate over Aubagio®* (teriflunomide) in patients…
MS Drug Therapies

September 25, 2019

Puzzling It Out – a Podcast series for MS Patients

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • Multiple Sclerosis Videos
    /
“Thoughts and Perspectives from a Clinical Psychologist” Click the banner to view a podcast series created for MS Patients. Visit…
Alternative therapies and devices for Multiple Sclerosis (MS)

September 24, 2019

Arthritis group offers first guidelines for patients who use CBD for joint pain

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • CANNABIS
    /
Sept 24, 2019 As seen on NBC’s Today show By Erika Edwards CBD has exploded in popularity over the last year,…
Alternative therapies and devices for Multiple Sclerosis (MS)

September 23, 2019

Sanofi and Happify Health solidify collaboration around prescription DTx designed to address mental health in people with MS

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
September 2019 – Companies plan to seek FDA clearance for digital therapeutics approach – The list of physical symptoms of…
Alternative therapies and devices for Multiple Sclerosis (MS)

September 23, 2019

EMD Serono Initiates Pivotal Phase III Program for Investigational Evobrutinib in Relapsing Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
EVOLUTION RMS 1 and 2 pivotal Phase III trials will investigate the efficacy and safety of evobrutinib in relapsing multiple…
MS Drug Therapies

Categories

Latest Blog Posts